Iovance Biotherapeutics (IOVA) Earnings Analysis
Iovance Biotherapeutics (IOVA) has no confirmed upcoming earnings date. Last quarter (2025-11-06) it beat with EPS -0.25 USD vs -0.29 USD est (+13.8%). It has beaten estimates in 3/3 recent quarters (100%). Trailing P/E -5.62.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does IOVA next report earnings?
No confirmed upcoming earnings date is currently scheduled for IOVA. This page updates as the calendar is published.
IOVA earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-11-06 | -0.25 USD | -0.29 USD | +13.8% | Beat |
| 2025-02-27 | -0.26 USD | -0.26 USD | 0% | Beat |
| 2024-11-07 | -0.28 USD | -0.31 USD | +9.7% | Beat |
Beat rate: 3/3 (100%) over reported quarters with consensus data.
IOVA valuation and analyst view
| Trailing P/E | -5.62 |
|---|---|
| Trailing EPS | -0.84552 USD |
| Price / book | 3.00 |
| Dividend yield | 0.00% |
| Market cap | 1.85B |
| Analyst consensus | Buy (15 buy / 5 hold / 0 sell) |
| Avg price target | 5 USD |
Related research pages
Frequently asked questions
When is Iovance Biotherapeutics (IOVA)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for IOVA. This page updates as the calendar is published.
Did IOVA beat earnings last quarter?
In its 2025-11-06 report, IOVA posted EPS of -0.25 USD versus a -0.29 USD estimate — a beat of 13.8%.
What is IOVA's earnings track record?
Over the last 3 reported quarters with consensus data, IOVA beat estimates 3 times (100%).
What is IOVA's current P/E ratio and EPS?
IOVA trades at a trailing P/E of -5.62 on trailing EPS of -0.8455213841452196 USD.
What do analysts rate IOVA?
Analyst consensus is "Buy" across 20 ratings (0 strong buy, 15 buy, 5 hold, 0 sell, 0 strong sell). Average 12-month price target: 5 USD.